Massive 2000-Person trial tests new hope for millions with dry eyes
NCT ID NCT07457021
Summary
This study aims to understand how well an approved eye drop works for dry eye disease in everyday medical practice. Researchers will follow 2000 adults with dry eye related to meibomian gland dysfunction for 12 weeks. They will track safety, side effects, and whether the drops improve symptoms like dryness, grittiness, and burning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xiamen Eye Center Affiliated to Xiamen University
Xiamen, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.